| 发明名称 |
VACCINE |
| 摘要 |
<p>The standard dose of polio vaccines contains 40 D-antigen units of inactivated poliovirus type 1 (Mahoney), 8 D-antigen units of inactivated poliovirus type 2 (MEF-1), and 32 D-antigens units of inactivated poliovirus type 3 (Saukett). The present invention teaches that reduced doses of inactivated poliovirus can maintain an adequate or improved level of protection against polio.</p> |
| 申请公布号 |
KR20090058552(A) |
申请公布日期 |
2009.06.09 |
| 申请号 |
KR20097007120 |
申请日期 |
2009.04.07 |
| 申请人 |
GLAXOSMITHKLINE BIOLOGICALS S.A. |
发明人 |
DE HEMPTINNE HERVE;DUCHENE MICHEL;MARY ANNE;SONVEAUX MARC |
| 分类号 |
A61K39/13;A61K39/29;A61K39/295;A61P31/12 |
主分类号 |
A61K39/13 |
| 代理机构 |
|
代理人 |
|
| 主权项 |
|
| 地址 |
|
